Commentary|Videos|April 22, 2024
Current State of the Pharma Sales and Marketing Sales Force
Author(s)Mike Hollan, Miranda Schmalfuhs
Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion
Advertisement
Executive Roundtable Participants:
- Ian Baer, Founder and Chief Soothsayer, Sooth
- Andrew Bast, Chief Strategy Officer, Greater Than One
- Jay Shah, Senior Solutions Engineer, MMIT
- Simon Arkell, CEO and Co-Founder, Ryght
- Glen Saunders, VP of Product Management and Strategy, Skipta
- John Kenny, SVP and Head of Strategic Planning, EVERSANA
Moderated by Mike Hollan
Video edited by Miranda Schmalfuhs
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5